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ApoptosisCoronaviruses (CoVs) are a group of single stranded RNA viruses, of which some of them such as SARS-CoV,
MERS-CoV, and SARS-CoV-2 are associated with deadly worldwide human diseases. Coronavirus disease-2019
(COVID-19), a condition caused by SARS-CoV-2, results in acute lung injury (ALI)/acute respiratory distress syn-
drome (ARDS) associatedwith highmortality in the elderly and in peoplewith underlying comorbidities. Results
from several studies suggest that CoVs localize in mitochondria and interact with mitochondrial protein translo-
cationmachinery to target their encoded products tomitochondria. Coronaviruses encode a number of proteins;
this process is essential for viral replication through inhibiting degradation of viral proteins and host misfolded
proteins including those inmitochondria. These viruses seem tomaintain their replication by alteringmitochon-
drial dynamics and targeting mitochondrial-associated antiviral signaling (MAVS), allowing them to evade host
innate immunity. Coronaviruses infections such as COVID-19 are more severe in aging patients. Since endoge-
nous melatonin levels are often dramatically reduced in the aged and because it is a potent anti-inflammatory
agent, melatonin has been proposed to be useful in CoVs infections by altering proteasomal and mitochondrial
activities. Melatonin inhibits mitochondrial fission due to its antioxidant and inhibitory effects on cytosolic
calcium overload. The collective data suggests that melatonin may mediate mitochondrial adaptations through
regulating bothmitochondrial dynamics and biogenesis.Wepropose thatmelatoninmay inhibit SARS-CoV-2-in-
duced cell damage by regulating mitochondrial physiology.
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Mitochondria are double membrane-bound organelles, which are
closely integratedwith cellularmetabolism and ultimately with cellular
survival (Norberg, Orrenius, & Zhivotovsky, 2010; Rambold &
Lippincott-Schwartz, 2011). A major function attributed to the mito-
chondria is the generation of cellular energy in the form of adenosine
triphosphate (ATP) through respiration. Furthermore, mitochondria
play important roles in cell signaling pathways including signaling for
calcium homeostasis, inflammation, proliferation, autophagy and apo-
ptosis (Schapira, 2006; Smith, Hartley, Cocheme, & Murphy, 2012).
Themitochondrial mass of cells varies depending on cellular energy de-
mands; cellswithhighmetabolic activity have the largest amount ofmi-
tochondria, e.g., cardiomyocytes. Cellular mitochondrial content is
adjusted through the competing processes of organelle biogenesis and
degradation by complex intracellular and extracellular signaling path-
ways (Scarpulla, Vega, & Kelly, 2012). The outer mitochondrial mem-
brane contains proteins that form voltage-dependent anion-selective
channels, allowing the free translocation of uncharged molecules up
to ~5,000 Daltons into the intermembrane space in the open configura-
tion (Mokranjac & Neupert, 2009). The inner mitochondrial membrane
has restricted permeability and is loaded with protein complexes
including reduced nicotinamide adenine dinucleotide (NADH)
dehydrogenase-ubiquinone oxidoreductase (complex I), succinate
dehydrogenase-ubiquinone oxidoreductase (complex II), ubiquinone-
cytochrome c oxidoreductase (complex III), cytochrome c oxidase
(complex IV), and ATP synthase (complex V); these proteins are in-
volved in the ATP synthesis through oxidative phosphorylation (Green
& Kroemer, 2004; Green & Reed, 1998). During electron transport
through the respiratory chain, protein complexes (I, II, IV) use donated
electrons to pump protons into the intermembrane space, creating a
proton gradient which drives formation of ATP by complex V (Green
& Kroemer, 2004; Green & Reed, 1998).
Mitochondria contain several circularDNA complexes (mitochon-
drial DNA,mtDNA), eachmolecule ofwhich contains 37 genes encoding
13 key subunits of respiratory-chain complexes and the necessary RNA
machinery including two ribosomal RNAs (16S rRNAand 12S rRNA) and
22 transfer RNAs, which are required for translation of mtDNA tran-
scripts (Wallace, 2005). The mitochondrial DNA genome encodes com-
ponents of the respiratory-chain complexes I, III, IV, and V. Complex II
subunits and remaining mitochondrial proteins are encoded by the nu-
clear genome, synthesized as precursors on cytosolic ribosomes and
subsequently imported into the correct mitochondrial compartment
through specific protein translocationmachineries. These protein trans-
location processes are part of a dynamic network which perform func-
tions related to mitochondrial biogenesis, dynamics, and quality
control under physiological and pathophysiological conditions
(Wallace, 2005; Wiedemann & Pfanner, 2017). The majority of mito-
chondrial proteins are synthesized as the unfolded form and then
transported into the matrix where folding ensues; failure of this com-
plex series of events results in the accumulation of unfolded or
misfolded proteins within mitochondria triggering disruption of mito-
chondrial functions (Tatsuta, 2009). Mitochondrial protein quality con-
trol is essential to maintain cellular homeostasis under normal and
stressful conditions. Several surveillance mechanisms monitor mito-
chondrial integrity and protein-folding homeostasis at molecular,
organellar, and cellular levels.
The first line of quality control is monitored by an elaborate network
of molecular chaperones and proteases, which prevents the2
accumulation of misfolded proteins in the various mitochondrial com-
partments (Baker, Tatsuta, & Langer, 2011). The second line of quality
control occurs at the organellar level; because of the dynamic nature
of this organelle, mitochondria constantly undergo fission and fusion
events through dynamin-related GTPases in the outer and inner mito-
chondrial membrane (Hoppins, Lackner, & Nunnari, 2007). This dy-
namic process regulates mitochondrial function by recruiting healthy
mitochondria to subcellular compartments, content exchange within a
mitochondrial network, changes in mitochondrial morphology and
clearance of defective organelles via mitophagy (Twig et al., 2008). Fi-
nally, at the cellular level, the quality control is maintained by pro-
grammed cell death (apoptosis); when molecular damage becomes
extreme and the majority of organelles become irreparable, cell death
occurs through apoptosis (Q. Cai & Tammineni, 2016). Disruptions in
any of these processes results in the impairment of mitochondrial func-
tion and cellular metabolism, leading to disturbed homeostasis and dis-
ease (H. Chen & Chan, 2009). Herein, we briefly review the potential
effect of coronaviruses (CoVs) on themechanisms involved in themito-
chondrial protein quality control and, thereafter, describe the potential
modulatory effect of melatonin on these molecular pathways.
2. Coronaviruses
Coronaviruses (CoVs) are a group of enveloped, positive-sense, and
single stranded RNA viruses of ~30 kb, which share a common protein
structure composed of spike (S), envelope (E), membrane (M) and nu-
cleocapsid (N). Coronaviruses are classified into four (α, β, γ, and δ)
genera; to date, seven members of α- and β-CoVs are identified as
human pathogens. Four viruses (229E, NL63, HKU1, and OC43) express
lowpathogenicity and generally inducemild respiratory symptoms. The
other three (severe acute respiratory syndrome coronavirus (SARS-
CoV), middle-east respiratory syndrome coronavirus (MERS-CoV), and
SARS-CoV-2) are associated with severe respiratory comorbidities, and
caused large-scaled pandemics in 2003, 2012 and late 2019, respec-
tively (J. F.-W. Chan et al., 2020; de Wilde, Snijder, Kikkert, & van
Hemert, 2017; R. Lu et al., 2020; Weiss & Leibowitz, 2011). During
their emergence, SARS-CoV initially infected more than 8000 individ-
uals (with 10% mortality) while MERS-CoV reportedly infected ~2500
people (with 35% mortality). As of September of 2020, outbreak of the
new identified member of β-CoV genera, SARS-CoV-2, infected and es-
timated 26 million with a cumulative mortality rate of ~5% (J. F.-W.
Chan et al., 2020; de Wilde et al., 2017; R. Lu et al., 2020; Weiss &
Leibowitz, 2011). SARS-CoV-2 has a genome sequence with ~80% iden-
tity to SARS-CoV and ~50% to MERS-CoV. Coronavirus disease-2019
(COVID-19), a condition caused by SARS-CoV-2, is highly pathogenic
and mainly spreads via respiratory droplets. COVID-19 patients mani-
fest different non-specific symptoms including fever, cough,myalgia, fa-
tigue, and diarrhea. However, severe progression of COVID-19 results in
acute lung injury (ALI)/acute respiratory distress syndrome (ARDS) as-
sociated with high mortality in elderly and people with underlying dis-
eases (Ahmed, 2020; Salehi, Abedi, Balakrishnan, & Gholamrezanezhad,
2020).
3. Coronavirus–host interactions
Viral respiratory infections such as CoVs promote the generation of
reactive oxygen species (ROS) and inflammatory cytokines (Khomich,
Kochetkov, Bartosch, & Ivanov, 2018; Yang, 2020). In peripheral blood
mononuclear cells (PBMC) of SARS patients, SARS-CoV up-regulates
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transcription factors, and cytokines (Shao et al., 2006). Zinc finger pro-
tein 331 (ZNF331) and FBJ murine osteosarcoma viral oncogene homo-
log (FOS) are two redox-sensitive transcription factors up-regulated by
SARS-CoV. The transcription factor FOS is a component of redox-
sensitive transcription factor complex activator protein 1 (AP-1); AP-1
pathway is also activated by nucleocapsid (N) protein of SARS-CoV
(Shao et al., 2006). Angiotensin II (Ang-II), a component of renin–
angiotensin system, triggers severe acute lung injury in SARS-CoV and
SARS-CoV-2; this protein is activated by mitochondrial-induced ROS
and induces the activation of AP-1 by binding to the Ang-II type 1 recep-
tor (AT1R) (Gurwitz, 2020; D. Liu, Gao, Roy, Cornish, & Zucker, 2006;
Wu et al., 2005). As a result of Ang-II activation, AP-1 up-regulates the
expression of AT1R leading to the exacerbation of Ang-II signaling
(Haack, Mitra, & Zucker, 2013). The angiotensin converting enzyme 2
(ACE2) is used by SARS-CoV and SARS-CoV-2 to enter ACE2-
expressing cells including type II alveolar epithelial cells in the lung,
esophageal upper epithelial cells and absorptive enterocytes of ileum
and colon (Hoffmann et al., 2020; H. Zhang et al., 2020; P. Zhou et al.,
2020). Although SARS-CoV and SARS-CoV-2 use ACE2 to gain initial
entry into cells, continued viral infection and replication is associated
with the down-regulation of ACE2 expression resulting in the impair-
ment of enzyme protective effects in organs (Gurwitz, 2020; Kuba
et al., 2005; Y. Liu et al., 2020). Due to the role of ACE2 in thedegradation
of Ang-II, down-regulation of ACE2 activity leads to the Ang-II accumu-
lation and local renin–angiotensin–aldosterone system (RAAS) activa-
tion in lungs. The elevated level of plasma Ang-II has been detected in
patients with COVID-19, with the level of this protein being linearly as-
sociated with the total viral load and degree of lung injury (Y. Liu et al.,
2020). Blockade of RAAS in mice exposed to SARS-CoV spike protein
limits virus-induced acute lung injury (Kuba et al., 2005). Findings
from these studies suggest that restoration of ACE2 and inhibition of
Ang-II may be useful for treatment of COVID-19 disease.
Up-regulation of the expression of mitochondrial genes in PBMC im-
plies that SARS-CoV markedly impacts mitochondrial function (Shao
et al., 2006). SARS-CoV accessory protein 3b, as one of the interferon an-
tagonist encoded by SARS-CoV genome, is reported to be located in the
mitochondria (Q. Li et al., 2005). Furthermore, SARS-CoV non-structural
protein 10 (NSP10), a critical co-factor for activation ofmultiple replica-
tive enzymes, specifically interactswith theNADH-ubiquinone oxidore-
ductase chain 4L (ND4L) protein, a subunit of the respiratory chain
complex I, and with cytochrome oxidase II, the second subunit of
respiratory complex IV, in the mitochondria (Yuan et al., 2006). Master
Regulator Analyses suggests that the Complex I subunit NDUFA10 is
down-regulated in bronchial epithelial cells infected by MERS and
SARS-CoV-2 (Guzzi, Mercatelli, Ceraolo, & Giorgi, 2020). This SARS-
CoV-2-induced mitochondrial dysfunction triggers mitochondrial ROS
production. Overproduction of ROS induces the expression of hypoxia-
inducible factor-1α (HIF-1α), which this protein strongly induces gly-
colysis and IL-1β transcription in SARS-CoV-2-infected monocytes;
glycolytic flux is reported to be sufficient for replication of SARS-CoV-
2 in monocytes and response of SARS-CoV-2-infectd monocyte. Treat-
ment of CoV-2-infected monocytes with antioxidants can inhibit
up-regulation of HIF-1α and its target genes including ACE2 and IL-1β.
Since the level of HIF-1α increases in the blood monocytes of severe
COVID-19 patients, the use of antioxidant may be a therapeutic
strategy to inhibit mtROS/HIF-1α/glycolysis axis in COVID-19 patients
(Codo et al., 2020).
Mitochondrial morphodynamics influence the innate immune sig-
naling through enhancing type I interferon (IFN-I) synthesis. This func-
tion is mediated by the activation of mitochondrial associated antiviral
signaling (MAVS) by cytosolic pattern recognition receptors (PRRs) in-
cluding RIG-I like receptors (RLRs) such as retinoic acid-inducible
gene I (RIG-I) and melanoma differentiation-associated gene-5
(MDA5); these genes recognize pathogen associatedmolecular patterns
(PAMPs) in the form of viral double-stranded RNA (dsRNA) motifs3
(Khan, Syed, Kim, & Siddiqui, 2015); this suggests a relevant interplay
between mitochondria and innate immunity. During the primary re-
sponses of host cells, RIG-I and MDA5 detect cytosolic RNA viruses,
which contributes to the formation of MAVS signal complex on mito-
chondria. Activation of MAVS results in the activation of TANK-binding
kinase 1 (TBK1) and subsequent phosphorylation of interferon regula-
tory factor 3 (IRF3), proteins typically associated with cytosolic chaper-
one Hsp90. Upon activation, IRF3 translocates into the nucleus and
promotes the early production of IFN-I, establishing antiviral state by
inhibiting viral replication (X.-Y. Liu, Wei, Shi, Shan, & Wang, 2010).
SARS-CoV open reading frames (ORF)-9b protein localizes in mito-
chondria and targets the mitochondrial MAVS signalosome; ORF-9b
promotes the degradation of MAVS leading to the loss of TRAF3 and
TRAF6 signaling molecules, which play essential roles in antiviral re-
sponses (Shi et al., 2014); TRAF3 functions as an adapter protein, bridg-
ing MAVS with the downstream signaling complex including TBK1,
which is essential for IRF3 activation (Lui et al., 2016). SARS-CoV E,
ORF3a and ORF8b proteins are recognized by PRRs such as NOD-like re-
ceptors protein 3 (NLRP3) on the cell membrane; NLRP3 is recruited to
MAVS to form an NLRP3 inflammasome accompanied by adaptor pro-
tein ASC (apoptosis-associated speck-like protein containing a caspase
recruitment domain) and pro-caspase-1 (I.-Y. Chen, Moriyama, Chang,
& Ichinohe, 2019; Nieto-Torres et al., 2015; Shi, Nabar, Huang, & Kehrl,
2019). The activation of the NLRP3 inflammasome is also reported in
hDPP4-transgenic mice and human macrophages infected by MERS-
CoV (Y. Jiang et al., 2019). This contributes to the activation of
caspase-1 which catalyzes the proteolytic activation and secretion of
proinflammatory cytokines including interleukin 1 beta (IL-1β) and
IL-18. The active IL-1β and IL-18 are released into the extracellular
space and recruit inflammatory cells which accumulate and exaggerate
the inflammatory response, thereby inducing cell pyroptosis, a highly
inflammatory form of programmed cell death (Yang, 2020). Compres-
sion of the mitochondria localized ORFs encoded by SARS-CoV and
SARS-CoV-2 revealed that except for ORF3b, the amino acid sequences
of SARS-CoV-2 ORFs are similar to SARS-CoV ORFs (ORF7a, -8a, and
-9b); these ORFs proteins are localized in the mitochondria and pro-
mote viral replication (Singh, Chaubey, Chen, & Suravajhala, 2020b).
These similarities suggest that the patterns and modes of SARS-CoV-2
interaction with host antiviral defense may be similar. The storm of
proinflammatory cytokines observed in the severe cases of COVID-19
indicates that SARS-CoV-2 may induce the activation of NLRP3
inflammasome, thereby causing cell pyroptosis, especially in lympho-
cytes (Yang, 2020).
4. Melatonin
4.1. The pharmacokinetic, pharmacodynamics and safety of melatonin
Melatonin is a molecule synthetized by the pineal gland and locally
by perhaps in all organs and cells. It has been identified inmany cells in-
cluding blood cells, bone marrow, cochlea, retina, lens, accessory sex
glands, skin, etc. The evidence is now reasonably strong that the mito-
chondria of all cells probably synthesize melatonin and only 5% or less
of the total melatonin produced comes from the pineal gland
(Hosseinzadeh et al., 2019; Pourhanifeh, Dehdashtian, Hosseinzadeh,
Sezavar, & Mehrzadi, 2020; Russel J Reiter et al., 2019)
Exogenous melatonin has been showed a number of clinical effects
in various disorders including sleep disorders, chronic obstructive pul-
monary disease and hypertension (Andersen, Gögenur, Rosenberg, &
Reiter, 2016a).Melatonin in oral immediate-release formulations is rap-
idly absorbed from the small intestine by first-order kinetics. Time to
maximal concentration and elimination half-life are approximately 50
and 45 min, respectively, following oral administration. In oral slow-
release formulations of melatonin, time to maximal concentration and
elimination half-life prolongs up to 167 and 91 min, respectively
(Harpsøe, Andersen, Gögenur, & Rosenberg, 2015). Maximal serum
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variation in oral administration of melatonin; these inter-individual
variationsmay obviously result from differences in absorption, distribu-
tion, metabolism or excretion of the drug. The average bioavailability of
orally administeredmelatonin is approximately 15 %; this low degree of
bioavailabilitymay result frompoor oral absorption, extensive first-pass
metabolism in the liver or a combination of both (Harpsøe et al., 2015).
Data from animal and human studies indicates that melatonin has high
biological safety, even in extreme doses. Randomized clinical studies
demonstrate mild adverse effects including dizziness, headache, nausea
and sleepiness following the long-term administration of melatonin
(Andersen, Gögenur, Rosenberg, & Reiter, 2016b). A randomized trial
has reported that orally administrated melatonin in a dose of 25 mg/
day for 6 months could significantly reduce serum concentrations of in-
flammatory cytokines including IL-6 and IL-1β (Sánchez-López et al.,
2018). Furthermore, severely affected ALS patients treated with
300 mg/day melatonin for 2 years did not show any adverse effects
(Weishaupt et al., 2006). Due to the destructive inflammation in severe
COVID-19 patients, the sufficient amounts of melatonin are required to
overcome SARS-CoV-2-induced pathological alterations; this goal is not
achieved with physiological levels of melatonin (Kleszczyński,
Slominski, Steinbrink, & Reiter, 2020). Administration of melatonin in
mice infected with H1N1 virus could reduce the mortality in a dose of
100 mg/kg/day (200 mg/kg/48 h) (Huang et al., 2019). Conversion of
murine dose to the human dose results in a human equivalent dose
for melatonin of 8.1 mg/kg/day, a daily dose of 600 mg for a 75-kg
human (Kleszczyński et al., 2020). Similar dose of melatonin
(8.1 mg/kg/day and 8.2 mg/kg/day) has been used in a prospective
nonrandomized nonblind case–control study on neonates with neona-
tal sepsis (El-Gendy, El-Hawy, & Hassan, 2018). Since no adverse effects
have been reported by this clinical study, it is estimated that a daily dose
of 600 mg of melatonin may be useful for treatment of deadly viral in-
fectious diseases, including COVID-19 (Kleszczyński et al., 2020). A
case series study performed by Castillo et al. evaluated the effect of mel-
atonin (36–72 mg/day) as an adjuvant therapy in 10 patients admitted
with COVID19 pneumonia. In 7 patients, who COVID-19 was diagnosed
by positive SARS-CoV-2 reverse transcription polymerase test, the hos-
pitalization lasted an average of 8.6 days after initiation of melatonin
treatment. In 3 patients, test was negative, but it was deemed to be
false because of the history, symptoms, chest imaging findings and the
level of inflammatory parameters in patients; the hospitalization in
these patients lasted an average of 7.3 days after initiation of melatonin
treatment. The average of hospitalization was 13 days for patients who
did not receive melatonin. Sleepiness was the only side-effect reported
in patient treated with melatonin. These findings suggest that
melatonin may be a promising agent as an adjuvant therapy against
COVID-19; however, further studies are needed to evaluate the effect
of different doses of melatonin in patients with severe COVID-19
(Castillo et al., 2020).
As a potent anti-oxidant, melatonin protects cells from oxidative
stress-induced damage through detoxifying ROS and elevating cellular
anti-oxidant enzymes (Dehdashtian, Pourhanifeh, Hemati, Mehrzadi,
& Hosseinzadeh, 2020; Shahriari et al., 2020). Melatonin regulates vari-
ous signalingpathways involved in inflammation, apoptosis, autophagy,
angiogenesis, etc. (M. H. Mehrzadi, Hosseinzadeh, Juybari, & Mehrzadi,
2020). Melatonin influences cell physiology through both
receptor-dependent and receptor-independent actions; the receptor-
independent actions of melatonin are mediated by its ability to scav-
enge free radicals and its receptor-dependent actions are related to an
interaction with membrane (MT1 and MT2) or nuclear RAR-related or-
phan receptors (RORs) and the retinoid Z receptors (RZRs)) receptors
(Russell J Reiter et al., 2007). The MT1 and MT2 receptors are
membrane-boundGprotein-coupled receptors (GPCRs),which are sug-
gested to express in various tissues, perhaps, in almost all nucleated
cells (Ruediger Hardeland et al., 2011). The MT2 receptors are reported
to express in the nucleus, in addition to the cytoplasmic membrane4
(Ahluwalia, Brzozowska, Hoa, Jones, & Tarnawski, 2018a). Furthermore,
MT1 andMT2 receptors are present in mitochondrial membranes, indi-
cating the role of melatonin in the mitochondrial signaling (Ahluwalia,
Brzozowska, Hoa, Jones, & Tarnawski, 2018b). However, the expression
pattern of MT1 and MT2 receptors varies depending on the cell-type
and species; for example, mouse cerebellar granule cells exclusively ex-
press MT1 receptor, while the same cells in human express both MT1
andMT2 receptors (Imbesi, Uz, Dzitoyeva, Giusti, &Manev, 2008a). Fur-
thermore, the expression pattern of MT1 and MT2 receptors changes
during development, aging and various pathological conditions
(Zlotos, Jockers, Cecon, Rivara, &Witt-Enderby, 2014). Thesemelatonin
membrane receptors have the ability to form homo-dimers or hetero-
dimers, which these dimerizations may alter receptor pharmacology,
signaling and regulation (Imbesi, Uz, Dzitoyeva, Giusti, & Manev,
2008b; Jockers, Maurice, Boutin, & Delagrange, 2008a). The MT1 and
MT2 receptors couple to pertussis toxin–sensitive Gi and –insensitive
Gq proteins. Binding of melatonin to these receptors leads to the inhibi-
tion of forskolin-stimulated cyclic adenosine monophosphate (cAMP)
formation, protein kinase A signaling and phosphorylation of the
cAMP-responsive element binding (CREB) protein through Gi protein
activation (Hemati et al., 2020; Jockers, Maurice, Boutin, & Delagrange,
2008b). BothMT1 andMT2 receptors activate phospholipase C pathway
leading to the up-regulation of inositol triphosphate (IP3) and 1, 2-
diacylglycerol (DAG) levels through activation of Gq protein (Ng,
Leong, Liang, & Paxinos, 2017). The MT1 and MT2 receptors mediate
phosphorylation of c-Jun N-terminal kinase (JNK) through activation
of Gi and Gq proteins (A. S. L. Chan et al., 2002). The MT1 receptor has
been reported to activate mitogen-activated protein kinase kinases 1/
2/ extracellular signal-regulated kinases 1/2 pathway by Gi protein acti-
vation, while MT2 receptor activates this pathway through cooperative
activation of Gi and Gq proteins (M. Chen et al., 2020). Furthermore,
MT2 receptors inhibit cyclic guanosine monophosphate/protein kinase
G pathway upon Gi activation (Jockers et al., 2008a). Since dimerization
of MT1 and MT2 receptors alters signaling of these receptors, the re-
sponsiveness of cells to melatonin depends on the presence or absence
of MT1/MT2 heteromers. The effect of melatonin in the reduction of
forskolin-simulated cAMP production occurs only in cells expressing
bothMT1 andMT2 receptors (Cecon, Oishi, & Jockers, 2018). In cells ex-
pressing both MT1 and MT2 receptors, melatonin at a low nM concen-
tration inhibits extracellular signal-regulated kinase signaling rather
than its stimulation, while silence of either receptor results in the stim-
ulatory response of melatonin (Cecon et al., 2018).
4.2. Melatonin, a mitochondrial targeted molecule
Melatonin is synthesized from the amino acid L-tryptophan in a
four-step process; (I) formation of 5-hydroxytryptophan from
tryptophan by tryptophan hydroxylase, (II) decarboxylation of 5-
hydroxytryptophan by l-aromatic amino acid decarboxylase to form
5-hydroxytryptamine (5-HT, also called serotonin), (III) formation
of N-acetyl-5-hydroxytryptamine (N-acetyl serotonin) from serotonin
by arylalkylamine N-acetyltransferase/ serotonin N-acetyltransferase
(AANAT/SNAT) and (IV) conversion of N-acetyl serotonin to mela-
tonin (N-acetyl-5-methoxytryptamine) by N-acetylserotonin-O-
methyltransferase (ASMT) (Bahrami et al., 2018). The localization of
AANAT/SNAT enzyme in mitochondrial matrix and intermembrane
space suggests that mitochondria have the capacity to synthesizemela-
tonin (Kerenyi, Balogh, Somogyi, & Sotonyi, 1979; Kerenyi, Sotonyi, &
Somogyi, 1975). N-acetyl-coenzyme A (acetyl CoA), which is the neces-
sary co-factor for rate limiting enzyme AANAT/SNAT, is mainly synthe-
sized in the mitochondria (Russel J Reiter et al., 2019). The
concentration of acetyl CoA in the mitochondria is much higher than
other cellular compartments such as cytosol; themitochondrial concen-
tration of acetyl CoA can satisfy the Km of the AANAT (D.-X. Tan,
Manchester, Qin, & Reiter, 2016). Furthermore, oligopeptide trans-
porters (PEPT) 1/2 exist in the mitochondrial membrane, where they
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chondria against a gradient (Anderson & Reiter, 2019); the accumula-
tion of melatonin in the mitochondria would be expected to prevent
mitochondrial impairment in normal cells and to kill tumor cells. In
the mitochondria, melatonin also promotes pyruvate conversion to
acetyl-CoA through inhibiting mitochondrial enzyme pyruvate dehy-
drogenase kinase (PDK); an enzyme that inhibits pyruvate dehydroge-
nase complex (PDC) controlling the synthesis of acetyl-CoA from
pyruvate. In addition to being a co-factor for the AANAT/SNAT enzyme,
acetyl-CoA improves oxidative phosphorylation in the mitochondria
(Russel J Reiter et al., 2019).
The existence of N(1)-acetyl-N(2)-formyl-5-methoxykynuramine
(AFMK), themajormetabolite of melatonin, in themitochondria proves
that mitochondria also is a site of melatonin metabolism; AFMK is pro-
duced in the mitochondria through a pseudo-enzymatic process by in-
teraction of melatonin with cytochrome c, an iron-containing
hemoprotein. In the mitochondria, cytochrome c interacts with H2O2
and is converted to oxoferryl cytochrome c with pseudoperoxidase ac-
tivity. Oxoferryl derivative of cytochrome c oxidizes organic molecules
such as melatonin. The interaction between oxoferryl cytochrome c
and melatonin results in the restoration of normal redox cycle of cyto-
chrome c, essential for the maintenance of mitochondrial bioenergetics
under physiological and pathological conditions (Semak et al., 2005;
D.-X. Tan, Manchester, Esteban-Zubero, Zhou, & Reiter, 2015). Further-
more, melatonin can directly interact with ROS produced bymitochon-
dria to generate a variety of active metabolites with anti-oxidant
activity (Hosseinzadeh, Javad-Moosavi, Reiter, Yarahmadi, et al., 2018).
5. Anti-coronavirus actions of melatonin and its relation to
COVID-19
Cytokine storm is believed to be one of themajor causes of ARDS and
multiple-organ failure in viral infections, a situation which have been
reported in some cases of COVID-19 (Chousterman, Swirski, & Weber,
2017; L. Xu et al., 2019). Excessive release of pro-inflammatory cyto-
kines amplifies immune responses, but also causes serious cell, organ
and tissue damage (Huo et al., 2018; Oldstone & Rosen, 2014). Released
components from injured cells (mitochondrial DNA, cardiolipin, cyto-
chrome c and segments of nuclear DNA) alongwith pathogen remnants
are recognized by toll-like receptors (TLR4,7, and 9) as DAMPs and
PAMPs. Furthermore, Cyclic GMP/AMP synthase triggers a further
large-scale pro-inflammatory cytokine release known as the “secondary
cytokine storm”. Repetition of this vicious cycle results in extensive ap-
optosis, pyroptosis, and necrosis even of healthy cells (Huo et al., 2018).
In addition to these events, macrophages/monocytes switch their me-
tabolism from mitochondrial oxidative phosphorylation to aerobic gly-
colysis upon activation by PAMP or DAMP (Russel J Reiter, Ma, &
Sharma, 2020). This change allows these cells to providemetabolic pre-
cursors required for hyper cellular proliferation and cytokine synthesis
and release. PAMP and DAMP exaggerated innate immune responses
can effectively be regulated by melatonin (Srinivasan, Mohamed, &
Kato, 2012; Sung et al., 2018). In addition, reduced tissue and organ
damage associated with higher survival rates have been observed in
septic animal models (L. Xu et al., 2019) and in human subjects (Gitto
et al., 2001) after treatment by melatonin.
Clinical characteristics of COVID-19 include elevated levels of pro-
inflammatory cytokines (IL-10, IL-6, and TNF-α) accompanied by lym-
phopenia in severe cases. The severe progression of the disease may
lead to ALI/ARDS associated with high mortality in elderly and people
with underlying disease (Ahmed, 2020; Salehi et al., 2020). Advanced
age COVID-19 patients are more vulnerable to the disease due to the
weakened immune responses (Varricchi et al., 2020). Moreover, a num-
ber of studies have documented a significant decrease in physiological
levels of melatonin in the elderly (Scholtens, van Munster, van
Kempen, & de Rooij, 2016; Z.-Y. Zhao, Xie, Fu, Bogdan, & Touitou,
2002) and it is suggested that higher endogenous levels of melatonin5
may play a major positive role in healthy ageing and longevity (Rüdiger
Hardeland, 2013; Poeggeler, Reiter, Tan, Chen, & Manchester, 1993).
Thus, we hypothesize that lower concentrations of melatonin and lack
of well-functioning immune system in advanced age patients, as poor
prognostic factors, make them more vulnerable to COVID-19.
Melatonin influences immune-inflammatory processes through reg-
ulating immune cell function where it acts as both an activator and an
inhibitor of inflammatory and immune processes (Carrillo-Vico,
Guerrero, Lardone, & Reiter, 2005). Immune cells produce melatonin
via enzymatic pathways independent of the pineal gland (P. Lardone,
Carrillo-Vico, Molinero, Rubio, & Guerrero, 2009). Human lymphoid
cells are an important physiological source of melatonin; both resting
and phytohemagglutinin-stimulated human lymphocytes have the nec-
essarymachinery to synthesize and release large amounts ofmelatonin,
several times greater than the nocturnal physiological levels in human
serum. The endogenous synthesis of melatonin by lymphocytes is in-
volved in the regulation of IL-2 production acting as an intracrine, auto-
crine, and/or paracrine substance (Carrillo-Vico et al., 2004; P. J. Lardone
et al., 2006). The regulatory effect of melatonin on the function of im-
mune cells including T-lymphocytes, natural killer (NK) cells, eosino-
phils, macrophages, and mast cells may be due to its direct action on
melatonin receptors (Calvo, Gonzalez-Yanes, & Maldonado, 2013).
Melatonin exhibits exaggerated anti-inflammatory effects by inhibi-
tion of the production of pro-inflammatory cytokines, prostaglandins,
adhesion molecules and cyclooxygenase-2 (Favero, Franceschetti,
Bonomini, Rodella, & Rezzani, 2017; Pourhanifeh, Hosseinzadeh,
Dehdashtian, Hemati, & Mehrzadi, 2020). Scavenging free radicals and
enhancing the activity of antioxidant enzymes could be mechanisms
by which melatonin inhibits ROS-mediated activation of NF-κB, leading
to the inhibition of NF-κB nuclear translocation and subsequent inflam-
matory cytokine expressions (Maldonado, García-Moreno, González-
Yanes, & Calvo, 2016). Furthermore, melatonin directly inhibits
the NLRP3 inflammasome assembly and blunts NF-κB/NLRP3
inflammasome signaling activation through stimulation of nuclear
(ROR-α) receptors (García et al., 2015), a possible mechanism by
which melatonin exerts its mitochondrial protective effects (Ortiz
et al., 2015). Inhibition of NLRP3 inflammasome assembly bymelatonin
results in the reduction of caspase-1 and IL-1β activation (Fernández-
Gil et al., 2017; Y. Zhang et al., 2016). Based on anti-inflammatory,
anti-oxidative and immunoregulatory features, melatonin is suggested
to be protective against coronavirus-induced lung inflammation
(Juybari, Pourhanifeh, Hosseinzadeh, Hemati, & Mehrzadi, 2020; Russel
J Reiter et al., 2020).
6. Chaperone–protease networks maintain mitochondrial protein
quality
Chaperone proteins andATP-dependent proteases form an intercon-
nected functional network thatmonitors andmaintains protein homeo-
stasis in mitochondria (Fig 1) (Voos, 2013). Only 13 of the human
mitochondrial proteins are encoded by mtDNA and synthesized within
this organelle. The vast majority of the mitochondrial proteins are
encoded by the nuclear genome and synthesized by cytoplasmic ribo-
somes and subsequently imported into the organelle (Chacinska,
Koehler, Milenkovic, Lithgow, & Pfanner, 2009). Nuclear-encoded pro-
teins are presented in an unfolded state for efficient translocation across
the mitochondrial membranes. This translocation proceeds through
narrow pores formed by tightly-gated translocons including TOM
(translocase of the outer membrane) complex and TIM (translocase of
the inner membrane) complex called TIM23. TOM complex consists of
central pore forming Tom40 and receptor proteins Tom20, Tom22 and
Tom70 as well as the three small Tom proteins Tom5, Tom6 and
Tom7; small Tom proteins are not essential for TOM functions but are
required to promote assembly and stability of the TOM complex. Sub-
units of the TIM23 complex are divided into two groups of proteins,
one of which forms the membrane sector of the complex (Tim17, Tim
Fig. 1. The employment of chaperone–protease networks by CoVs and the regulatory effects ofmelatonin. Coronaviruses such as SARS-CoV and SARS-CoV-2 employmitochondrial protein
translocation machinery to inhibit antiviral cellular responses and maintain virus replication. SARS-CoV-2 interacts with Tom complex components. Interaction with may inhibit the
interaction of Tom70 with MAVS and induction of antiviral cellular responses (X.-Y. Liu et al., 2010). Polyproteins of SARS-CoV and MERS-CoV have deubiquitinating activity, which
influence infected cell ubiquitination. SARS-CoV interacts with proteasome through its nucleocapsid protein to suppress proteolytic activity of proteasomes; this contributes to the
inhibition of proteolysis of viral proteins and also suppression of host misfolded protein degradation (J. Lei et al., 2014; Lindner et al., 2005; Q. Wang et al., 2010). Melatonin affects
chaperone–protease networks through regulating the expression of HSPs, Tom20 and Tim23, and interacting with UPS machinery, this effects result in the inhibition of aberrant
protein accumulation in cells (Bonior et al., 2005; Corpas et al., 2018; Kireev et al., 2014; Martins Branco et al., 2010; S. Mehrzadi, Hemati, et al., 2020; Vriend & Reiter, 2014).
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other which pairs with the presequenced translocase-associated motor
(PAM), referred to as an importmotor, that drives the translocation into
the matrix space (Tim14/Pam18, Tim16/Pam16, Pam 17, Tim44,
mtHsp70 and Mge1) (Craig, 2018; Horvath et al., 2015; van der Laan,
Hutu, & Rehling, 2010).
Translocation of mitochondrial proteins through the TIM23 is driven
by the membrane potential across the inner membrane and the hydro-
lysis of ATP in the matrix (Banerjee, Gladkova, Mapa, Witte, &
Mokranjac, 2015). Mitochondrial precursor proteins have a strong ten-
dency to expose hydrophobic regions leading to the unwanted protein–6
protein interactions and protein aggregation. Therefore, these precursor
proteins need to bind a cytosolic chaperone for maintenance in an un-
folded import-competent conformation before interaction with TOM
translocase (Jensen & Johnson, 1999). Molecular chaperones that be-
long to the Hsp70, Hsp90 and mitochondrial import stimulation factor
(MSF) families facilitate translocation and folding reactions of mito-
chondrial proteins (Voos, 2013). These proteins deliver precursors to
the Tom70 receptor recognizing signals embedded in their internal
sequence of membrane-targeted precursors (Fan & Young, 2011).
Mitochondrial precursor proteins bind to Tom20 and Tom70
(Hsp70-dependent binding) or Tom20 alone (Hsp70-independent
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and Tom5 (Endo & Yamano, 2010). Cytosolic chaperone MSF binds to
Tom70 and delivers precursor proteins to Tom20 and Tom22 upon
ATP hydrolysis (Endo & Yamano, 2010). Upon translocation through
Tom, presequenced-containing proteins are directed into the TIM23
complex. The channel-forming Tim23 protein, Tim17 and Tim50 medi-
atemembrane potential-dependent insertion of precursor proteins into
the inner membrane (Mokranjac & Neupert, 2010). The Tim21 and
Mgr2 subunits of the TIM23 complex are suggested to be involved in
the interaction of the TIM23 complex with TOM complex as well as
with respiratory chain complexes; TIM23-respiratory chain coupling
may be important for the insertion of precursor proteins into the inner
membrane when the energetic activity of mitochondria is reduced
(Ieva et al., 2013; Mokranjac & Neupert, 2010).
The import motor PAM is crucial for the completion of precursor
protein import to the matrix in an ATP-dependent manner; Tim44 is a
coordinating subunit at the matrix side which binds to Tim17–Tim23
core of the complex. Furthermore, Tim44 interacts with mtHsp70 and
recruits the chaperone and its cochaperones (Pam18, Pam16, Pam17
and Mge1) to the translocation channel (Banerjee et al., 2015). The
sub-complex Pam17 is proposed to be involved in the organization
and recruitment of Pam18–Pam16 to the Tim17–Tim23 core of the
TIM23 complex (Van Der Laan et al., 2005). Sub-complexes Pam18
and Pam16 form a stable heterodimer stimulating the ATPase activity
of mtHsp70 coupled to multiple import reaction cycles (Y. Li et al.,
2004). Once proteins enter mitochondria, mtHSP70 (mitochondrial
heat shock 70 kDa protein) mediates the ATP-dependent import of mi-
tochondrial proteins into the mitochondrial matrix; mtHsp70 cooper-
ates with the mitochondrial chaperonin system consisting of Hsp60
and Hsp10, allowing the polypeptide chain to fold into the correct ter-
tiary conformation (Baker et al., 2011). The nucleotide exchange factor
Mge1 is a soluble matrix protein which mediates the release of ADP
from mtHsp70 enabling binding of ATP; this is followed by the release
of bound precursor proteins so that freed mtHsp70 can be engaged in
a new cycle (Mokranjac & Neupert, 2010).
Ubiquitin-proteasome system (UPS) is also involved in themonitor-
ing of protein quality control in the outer mitochondrial membrane.
When themolecular pathways are not able to refold misfolded proteins
to their native state, these proteins are targeted to the UPS pathway
(Baker, Palmer, & Stojanovski, 2014). The UPS machinery is important
in the removal of individual mitochondrial proteins, while the autoph-
agy pathway is responsible for the degradation of entire organelles by
lysosomes (Pan, Kondo, Le, & Jankovic, 2008). The UPS is a dynamic
multi-protein complex that eliminates impaired and/or nonfunctional
proteins. Ubiquitin is a 76 amino acid protein, which is covalently at-
tached to substrates through the formation of an isopeptide bond be-
tween the C-terminal glycine residue of ubiquitin and a lysine residue
in the substrate. Protein ubiquitination occurs through a cascade of
three enzymes including ubiquitin-activating E1 enzyme, ubiquitin-
conjugating E2 enzyme, and ubiquitin E3 ligase (Bragoszewski, Turek,
& Chacinska, 2017); Ubiquitin is activated by E1 enzymes and trans-
ferred to E2 enzymes. Ubiquitin is then conjugated to a carrier by E2 en-
zymes and ligated to the substrate proteins by E3 enzymes. The
attachment of one ubiquitin molecule to one substrate protein residue,
referred to as monoubiquitination, is a sufficient signal for proteasome-
mediated degradation of small proteins. Polyubiquitin chains are built
through the attachment of each subsequent ubiquitin molecule to one
lysine residue that is present in the preceding ubiquitin (Schrader,
Harstad, & Matouschek, 2009). Conversely, the ubiquitination process
is reversed by deubiquitinating enzymes (DUBs), counteracting E3 li-
gase activity by removing or editing the ubiquitin chains (Nijman
et al., 2005). The impairment of proteasome activity leads to mitochon-
drial dysfunction. Furthermore, various UPS components, as well as
DUBs, are localized in mitochondria. These reveal the association be-
tween mitochondria and the UPS; since mitochondria are the main
source of ROS and therefore are subject to oxidative damage, UPS in7
collaborationwith other quality control mechanisms removes damaged
mitochondrial proteins. In addition tomitochondrial proteins, excessive
level of ROS may oxidize and damage the proteasomal subunits
resulting in reduced catalytic activities (Ross, Olson, & Coppotelli,
2015). Therefore, mitochondrial dysfunction or proteasome system im-
pairment leads to the initiation of a vicious cycle, resulting in the pro-
gressive failure of both systems.
6.1. The employment of chaperone–protease networks by a coronavirus
infection
Viruses activate host cell machinery for the production of their own
components and virion assembly. Viruses keep evolving strategies to in-
terfere with cellular processes and create a favorable environment for
replication and survival (Williamson, DeBiasi, & Colberg-Poley, 2012).
The mitochondrial function are directly or indirectly disrupted by viral
infections; this results when viral proteins interfere with mitochondrial
function or physiological alterations associated with infection including
oxidative stress, hypoxia, impairment of calciumhomeostasis and endo-
plasmic reticulum (ER) stress (Khan et al., 2015; Kim, Ahn, Syed, &
Siddiqui, 2018). Viruses have evolved strategies to suppress the host an-
tiviral responses. Viruses can inflict mitochondrial damage that results
in the alteration in the mitochondrial morphodynamics to favor their
propagation (Kim et al., 2018).
Viruses may employ mitochondrial protein translocation machinery
to target their encoded products to mitochondria; a large number of
viral proteins localize in the mitochondria during replication where
they interact with mitochondrial proteins. Therefore, viruses manipu-
late mitochondrial functions including maintenance of oxidative bal-
ance, alteration of mitochondrial permeability transition pore, Δψm,
electron transport and ATP production (Williamson et al., 2012). Since
cellular chaperones involve protein folding processes, these are fre-
quently recruited by viruses during their life cycle. The level of Hsp70
increases following viral infection of cells; this virus-induced elevation
of Hsp70 levels is essential for virus proliferation (Mayer, 2005). The
SARS-CoV-2 ORF9b protein is reported to interact with Tom70 (H.-w.
Jiang et al., 2020). Upon RNA virus infection, Tom70 interacts with
MAVS and induces antiviral cellular responses through potentiating
IRF3-mediated gene expression (X.-Y. Liu et al., 2010). Therefore, asso-
ciation of SARS-CoV-2 Orf9b with Tom70 suppresses IFN-I response by
disturbing MAVS signalosome. Interaction of ORF9b with Tom70 may
influence IFN-I response through two possible mechanisms including
competing Orf9b with HSP90 for binding to Tom70 or impairment of
Tom70 function in the regulation of mitochondrial energy metabolism
leading to the lactic acid production and subsequent inhibition of IFN-I
responses (H.-w. Jiang et al., 2020). The RNA-Seq and matched ribo-
some profiling experiments show that the SARS-CoV-2 Nsp1 protein
shuts down host translation machinery; Nsp1 is reported to inhibit
translation of Tom22 and Tom40, which this can impair mitochondrial
import of precursor proteins (Rao et al., 2020). The SARS-CoV-2 ER-
resident protein Nsp4 is suggested to interact with components of
TIM complex and therefore affects IMM protein import (Gordon
et al., 2020). The SARS-CoV-2 ORF9b protein impedes the nuclear
trans-localization of NF-κB/p65 through disrupting K63-linked
polyubiquitination of NEMO; this results in the supression of IFN-I re-
sponse through inhibiting RIG-I-MAVS antiviral signaling (Wu et al.,
2021). The SARS-CoV-2 ORF9c and Nsp13 proteins target IFN pathway
through interacting with negative regulator of MAVS signaling
(NLRX1, NDFIP2) and MAVS effector TBK1, respectively (Gordon et al.,
2020). SARS-CoV-2 membrane glycoprotein M also interacts with
MAVS, contributing to the impairment of MAVS aggregation and its re-
cruitment of downstreamsignaling components including TRAF3, TBK1,
and IRF3, which this leads to the inhibition of downstream antiviral ef-
fector genes such as IFN-I. The SARS-CoVMprotein similarly suppresses
the stimulatory effect of RIG-I, MDA5, MAVS and TBK1 on IFN-I pro-
moter (Siu et al., 2009; Siu, Chan, Kok, Chiu-Yat Woo, & Jin, 2014). The
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interacting with TRAF3 and disrupting TRAF3–TBK1 association leading
to the inhibition of IRF3 phosphorylation (Lui et al., 2016).
Coronaviruses, as with many other viruses, subverts or manipulates
UPS for their own advantage. In addition to the role of UPS in eliminat-
ing cellularmisfolded proteins, UPS acts as a host defensemechanism to
eliminate viral components. Viruses can encode specific proteins with
E3-like or DUB-like activities or employ host UPS machinery to degrade
cellular proteins that restrict viral propagation and to evade the host im-
mune response (Luo, 2016; Raaben et al., 2010). Depending on the coro-
navirus replication, a functional ubiquitin proteasome pathway is
suggested. In the case of wild-type SARS-CoV (strain Frankfurt-1) and
recombinant CoVs feline infectious peritonitis virus (FIPV)Δ3abcFL,
MHV-EFLM, MHV-nsp2EGFP and SARS-CoV-GFP, the replication of vi-
ruses is impaired upon proteasomal inhibition (Raaben, Posthuma,
et al., 2010; Schneider et al., 2012). However, treatment of C57BL/6
mice infected by MHV-A59 and A/J mice infected by MHV strain 1
(MHV-1) with a proteasome inhibitor resulted in increased viral titers
and pathology (Ma et al., 2010; Raaben, Grinwis, Rottier, & de Haan,
2010). Coronaviruses encode a number of proteins, enzymes, and unde-
fined domains which are essential for viral replication. The replicase
genes are encoded in two large open reading frames (ORF 1a and 1b)
situated in the 5′-proximal three quarters of the genome. This mecha-
nism produces two large viral polyproteins, pp1a and pp1ab, which
are further cleaved by viral proteases to produce functional nonstruc-
tural proteins (Báez-Santos, John, & Mesecar, 2015). The coronaviral
proteases, papain-like protease (PLpro) and 3C-like protease (3CLpro)
process the viral polyprotein in a coordinated manner; 3CLpr process
the C-terminal regions of the pp1a and pp1ab polyproteins, while
PLpro process the N-terminal regions of pp1a/pp1ab. In addition to
the processing of the viral polyproteins, it is established that SARS-
CoV PLpro andMERS-CoV PLpro have deubiquitinating activity that influ-
ence host cell ubiquitination (J. Lei et al., 2014; Lindner et al., 2005).
Therefore, deubiquitinating activity of SARS-CoV PLpro and MERS-CoV
PLpro inhibits degradation of viral proteins and host misfolded proteins
includingmitochondrial proteins. Since the structure of CoV PLpro is dif-
ferent from homologous host enzymes such as USP14, CoV PLpro could
be an important target for antivirals agents. Furthermore, SARS-CoV nu-
cleocapsid protein (SARS-CoV NP) interacts with proteasome subunit
p42; NP is postulated to be the central organizer of virus assembly.
The interaction of SARS-CoV NP with proteasome subunit p42 leads to
the suppression of the proteolytic activity of proteasomes; this results
in the impairment of proteolysis of viral proteins and evasion of SARS-
CoV from immune effectors (Q. Wang et al., 2010). It is suggested that
this inhibition of proteolytic activity of proteasomes could also affect
the degradation of host misfolded proteins (Fig 1).
6.2. The regulatory effect of melatonin on chaperone–protease networks
Melatonin regulates the expression of HSPs includingHSP60, HSP70,
HSP90 in various cells and after different stimuli (Bonior, Jaworek,
Konturek, & Pawlik, 2005; Kireev, Vara, Viña, & Tresguerres, 2014). In
oxidative stress conditions associated with the induction of HSP70 ex-
pression, melatonin restores the level of HSP70 (Ozacmak, Barut, &
Ozacmak, 2009). The impairment of anti-oxidant defense results in
the induction of HSP70 expression. The overexpression of HSP70 is pro-
posed to be protective bydirectly impeding inflammation and cell death
pathways including apoptosis and necrosis. Melatonin inhibits oxida-
tive stress-induced induction of HSP70 expression through normalizing
the impaired antioxidants status (Ozacmak et al., 2009). Melatonin also
improves mitochondrial protein import in oxidative stress condition.
Melatonin restores the expression of Tim23 and Tom20, which this ef-
fect results from the induction of adenosine monophosphate-activated
protein kinase (AMPK)/peroxisome proliferator-activated receptor-
gamma coactivator 1 alpha (PGC1α) pathway (Qi &Wang, 2020).Mela-
tonin regulatesmultiple cellular functions through interactingwith UPS8
machinery. Under pathogenic conditions such as hypoxia associated
with the excessive level of proteasomes, melatonin reduces the level
of Nedd4-1, an E3 ligase found most abundantly in neurons. Melatonin
is not demonstrated to have a direct effect on UPS similar to that of
bortezomib, a proteasome inhibitor (Vriend & Reiter, 2014). This effect
is mediated through affecting the otoferlin (OTOF), substrate RNA splic-
ing factor (SF3B2), importin 5 (IPO5), Hsc70 interacting protein (ST13),
fibroblast growth factor receptor 3 (FGFR3),Mx1/Mx2, which play roles
in RNA splicing and trafficking, growth factor and interferon signaling
(Yalcin et al., 2019). In cancer cells, melatonin is reported to affect the
same targets as bortezomib. The major proteins involved in cancer sus-
ceptibility including tumor suppressor protein p53, the cell cycle regula-
tor p27, vascular endothelial growth factor (VEGF), transcription factors
NF-κB, NRF2 and beta-catenin, and apoptotic and anti-apoptotic pro-
teins, all of which are controlled by UPS; these proteins could be a target
for bortezomib. The regulatory effect ofmelatonin on these signal trans-
duction proteins suggests that it may influence the activity of themajor
targets of bortezomib (Vriend & Reiter, 2014).
Melatonin exhibits neuroprotective and cellular health-promoting
effects by enhancing proteasomal activity in animal models of
Alzheimer’s disease-like pathology. Aging has a negative effect on the
activity of the proteasome in a variety of tissues leading to an elevated
vulnerability of cells to oxidative stress and inflammation; the loss of
protein clearance mechanisms is directly linked to the aging process.
Thus, melatonin by improving the activity of proteasome may inhibit
accumulation of aberrant proteins in cells (Corpas et al., 2018). During
aging, circadian disturbances result in a decline in melatonin produc-
tion, which contributes to a reduction of both proteasomal activity
and mitochondrial dysfunction (Martins Branco et al., 2010; S.
Mehrzadi, Hemati, Reiter, & Hosseinzadeh, 2020). Despite the direct
mitochondrial protective effect of melatonin, the methoxyindole may
also indirectly affect mitochondrial quality control by regulating
proteasomal activity and, likewise, regulating proteasomal activity by
affecting mitochondrial function (Fig 1) (Corpas et al., 2018; Martins
Branco et al., 2010; Mehrzadi, Hemati, et al., 2020). Although no study
has been performed on the effect of melatonin on coronavirus-
mediated disruption of chaperone–protease networks, the regulatory
effect ofmelatonin on the activity of HSPs and proteasomemay improve
mitochondrial function and limit the replication of CoVs such as SARS-
CoV-2. Given that COVID-19 is more severe in elderly patients, and
that the amount of both melatonin and the proteasome is reduced dur-
ing aging, it is possible that melatoninmay be useful during a COVID-19
infection, especially in elderly patients.
7. Mitochondrial dynamics and autophagy as a quality control axis
7.1. The regulation of mitochondrial fusion and fission
Mitochondrial dynamics refers to repetitive cycles of fusion and fis-
sion of the mitochondrial network. The balance between these opposing
processes regulates mitochondrial shape and influences mitochondrial
physiology, quality and homeostasis (Twig, Hyde, & Shirihai, 2008). A fu-
sion process is a route bywhichmatrixmetabolites, intactmtDNAcopies,
and mitochondrial membrane components are quickly exchanged and
equilibrated between neighboring mitochondria; fusion is a comple-
mentory mechanism for renewing the function of damaged mitochon-
dria (Mouli, Twig, & Shirihai, 2009). Mitochondrial fusion in mammals
is mediated by mitochondrial dynamin-related GTPases including the
mitofusins (Mfn1 and Mfn2) and optic atrophy 1 (OPA1). Mitofusins
are responsible for the outer mitochondrial membrane (OMM) fusion.
In addition to the involvement in mitochondrial fusion, Mfn2 localizes
in the endo/sarcoplasmic reticulum and regulates the mitochondria-
ER/sarcoplasmic contact site tethering (Filadi et al., 2015). Mitofusins in-
clude anN-terminal GTPase domain, two coiled-coil domains (also called
heptad-repeat domains, HR1 and HR2) and a bipartite carboxy-terminal
transmembrane domain. The transmembrane domain is responsible for
S. Mehrzadi, M.Y. Karimi, A. Fatemi et al. Pharmacology & Therapeutics 224 (2021) 107825anchoring mitofusins to the OMM. Both the GTPase and coiled-coil do-
mains are exposed to the cytosol and mediate MOM fusion in a
GTPase-dependent manner (Chandhok, Lazarou, & Neumann, 2018).
OPA1 is responsible for the inner mitochondrial membranes (IMM) fu-
sion (Wu, Zhang, & Ren, 2019a). Constitutive processing of OPA1 by a
number of proteases results in the generation of two isoforms of OPA1
including long-OPA1 (L-OPA1) and short-OPA1 (S-OPA1) (Ishihara,
Fujita, Oka, & Mihara, 2006). The L-OPA1 form is integral to the inner
membranewhile the S-OPA1 is located in the intermembrane space. Var-
ious proteases such as the rhomboid-related protease presenilin-
associated rhomboid-like (PARL), matrix AAA proteases (m-AAA;
paraplegin, AFG3L1 and AFG3L2) and intermembrane space AAA prote-
ases (i-AAA; Yme1L) are involved in OPA1 processing in mammals (J.
Zhao, Lendahl, & Nistér, 2013). Processing of OPA1 by proteases is regu-
lated both by ATP levels and by the inner membrane potential (Δψm),
implicating mitochondrial energetic status as a regulator of OPA1 pro-
cessing (X. Wang et al., 2014). The heterotypic interaction of L-OPA1
onone side of themembrane to cardiolipin on the other side of themem-
brane is suggested to be sufficient for mitochondrial fusion; GTP-
independent membrane tethering through L-OPA1 binding with
cardiolipin promotes GTP-hydrolysis-dependent membrane fusion,
modulated by the presence of S-OPA1 (Ban et al., 2017). The mitochon-
drial deacetylase SIRT3 directly deacetylates OPA1 and activates this pro-
tein by elevating its GTPase activity (Samant et al., 2014). Mitochondrial
fusion proteins are ubiquitylated by several E3-ligases including Parkin
and MARCH5/MITOL to be subsequently removed by proteases (Wu,
Zhang, & Ren, 2019b).Mitochondrial depolarization leads to the cleavage
of L-OPA1 by inducible protease OMA1 leading to a reduced mitochon-
drial fusion and autophagic degradation of mitochondrial organelles
(Ni, Williams, & Ding, 2015).
A mitochondrial fission process leads to the division of the organelle
into small and depolarized mitochondria. This process requires force
coming from the activity of the dynamin-like GTPase protein Drp 1, a
master regulator of mitochondrial division in most eukaryotic organ-
isms. The Drp 1 protein is a soluble protein containing an N-terminal
GTPase domain followed by a middle domain, a variable domain and a
c-terminal GTPase effector domain that is involved in self-assembly
(Pagliuso, Cossart, & Stavru, 2018).
Dynamin-related protein 1 is predominantly located in the cytosol,
where it associates with microtubules. In response to fission signals,
Drp1 is recruited to the mitochondrial surface where it forms ring-like
structures around the organelle. On mitochondrial OMM Drp1 presum-
ably docks on mitochondrial fission factor (Mff), the mitochondrial dy-
namic proteins 49 and 51 (MiD49 and MiD51) and Fission 1 (Fis1), its
OMM receptor (Pagliuso et al., 2018). The ER–mitochondria contacts
allow formation of Drp1 complexes at the site of fission. ER-associated
inverted formin 2 (Inf2) and the mitochondria-anchored formin-
activating protein Spire1C induce accumulation of actinfilaments around
the ER-mitochondria contact points; Ca2+mobilization from the ER trig-
gers actin redistribution around mitochondria (Moore, Wong, Simpson,
& Holzbaur, 2016; Wales et al., 2016). Actin filaments induce a pre-
constriction event leading to the reduction of mitochondrial cross-
sectional diameter which allows Drp1-driven secondary constriction to
promote fission (Moore et al., 2016). Then, Fis1, Mff, MiD49, and
MiD51 recruit GTPase DRP1 to fission sites. Although the interaction be-
tween Fis1 andDrp1 has aminor role in regulatingmitochondrialfission,
Fis1 may mediate mitophagy and certain types of stress-induced fission.
The self-assembly of Drp1 stimulates GTP hydrolysis which is likely to
drive conformational changes in these oligomeric protein complexes
which promote membrane scission (Lackner & Nunnari, 2009). The
mechanism by which IMM fission occurs remains elusive. This process
is suggested to be mediated by S-OPA1 isoforms and the IMM protein
MTP18 (MTFP1); however, it is speculated that the constriction of mito-
chondria by Drp1 and actin may be sufficient to drive both OMM and
IMM fission simultaneously (Wai & Langer, 2016).9
Mitochondrial translocation of Drp 1 depends on phosphorylation–
dephosphorylation of its residues such as Ser637, Ser-656 and
Ser-616. Dependent on internal parameters or on external parameters
including cell type, age or status, Drp1 phosphorylation at the same res-
idue may have opposite effects on the mitochondrial fission progress.
Phosphorylation of Drp1 at Ser-637 by a kinase anchoring protein 1
(AKAP1), a scaffold protein that recruits protein kinase A (PKA) and in-
tegrates several second messenger cascades to regulate mitochondrial
function, and Ca2+/calmodulin dependent protein kinase Iα induces
Drp1 translocation to mitochondria; however, Drp1 phosphorylation
at Ser-637 by cAMP-dependent protein kinase results in the inhibition
of Drp1 activity (Hu, Huang, & Li, 2017). Furthermore, activation of
AMPKinduces phosphorylation of Drp1 at Ser-637 leading to the inhibi-
tion of Drp1-mediated mitochondrial fission, thereby blocking ER
stress-associated NLRP3 inflammasome activation (J. Li et al., 2015).
Depolarized mitochondria produced by the fission machinery are
targeted by autophagy, as a receiver of the segregation output (Fig 2)
(Calvani et al., 2013).7.2. The regulation of mitochondria-selective autophagy (mitophagy)
Autophagy includes several sequential steps (I-V), which are
strictly regulated by more than 35 autophagy related genes (ATGs)
and their corresponding proteins. (I) Induction and phagophore nu-
cleation step is regulated by ULK1 (Unc-51-like kinase1 (mamma-
lian homologues of Atg1), Atg13, Atg101 and RB1CC1/FIP200) and
PI3 class III (class III PI3-kinase (Vps34), p150 (mammalian homolog
of Vps15) complexes. The ULK1 complex involved in autophagy
initiation and promotes activation of PI3 class III complex through
phosphorylation of Beclin-1; PI3 class III complex induces phago-
phore nucleation (Glick, Barth, & Macleod, 2010). (II) The phago-
phore elongation and autophagosome formation steps are
regulated by Atg9 protein and two ubiquitin-like (Atg12–Atg5/
Atg16L and Atg8/LC3-phophatidylethanolamine (PE)) conjugation
systems. (III) Autophagosome-lysosome fusion (autolysosome for-
mation) step is regulated by Atg14 (R. Liu, Zhi, & Zhong, 2015).
(IV) The degradation of sequestered cargo occurs in autophagosome
by lysosomal/vacuolar hydrolases. (V) Degraded macromolecules
are exported to the cytosol and recycled for the synthesis of essential
components to overcome various stress conditions (Mehrzadi,
Hemati, et al., 2020).
The level of autophagosome formation is negatively regulated by
mammalian target of rapamycin complex 1 (mTORC1), containing
GβL, a regulatory-associated protein of mTOR (raptor), PRAS40 and
mTOR. The inhibition of mTORC1 results in the activation of Vps34,
which is essential for the induction of phagophore nucleation.
Upon energy deprivation, AMPKactivates and promotes the autoph-
agy pathway through activation of ULK1, inactivation of mTORC1
and up-regulation of LC3 expression (Mehrzadi, Hemati, et al.,
2020).
The elimination of damaged and dysfunctionalmitochondria through
a selective autophagic process is termedmitophagy. The delivery of dam-
aged mitochondria to the phagophore is mediated by outer mitochon-
drial membrane (OMM)-spanning proteins including NIX/BNIP3L,
BNIP3, FUN14 domain containing 1 (FUNDC1), p62/SQSTM1 and histone
deacetylase 6 (HDAC6), which function as receptors for LC3-II (Higgins &
Coughlan, 2014; Saito & Sadoshima, 2015). Serine/threonine kinase
PTEN-induced putative kinase 1 (PINK1) and the E3 ubiquitin ligase
Parkin are the key regulators of mitophagy by promoting mitophagic
degradation of impaired mitochondria (Narendra, Tanaka, Suen, &
Youle, 2008). Upon mitochondrial depolarization, PINK1 and Parkin
physically associate and functionally cooperate in the identification and
selection of mitochondria for degradation via mitophagy (Fig 2)
(Higgins & Coughlan, 2014; L. Liu, Sakakibara, Chen, & Okamoto, 2014).
Fig. 2. Effects of CoVs on mitochondrial dynamics and autophagy as a quality control axis and the regulatory effect of melatonin. Coronaviruses impacts mitochondrial dynamics and
mitophagy. Coronaviruses such as SARS-CoV-2 inhibits mitochondrial fusion through suppressing deubiquitination of ubiquitylated forms of Mfn1 and Mfn2 by targeting
mitochondrial deubiquitinase (Singh, Chaubey, et al., 2020a). SARS-CoV promotes proteasomal degradation of Drp1 leading to induction of mitophagy (X.-Y. Liu et al., 2010). Some
CoVs elevate the ratio of LC3-II/LC3-I leading to the autophagosome accumulation in infected cells (Ko et al., 2017). SARS-CoV-2 targets USP30 protein and inhibits Parkin-mediated
mitophagy (Zarandi, Zinatizadeh, Zinatizadeh, Yousefi, & Rezaei, 2021). Difference in the effect of various CoVs on autophagy may result from the fact that autophagy inhibits the
replication of some viruses but promotes the replication of other (Guo et al., 2016b). Melatonin regulates mitochondrial dynamics through increasing Mfn2 and OPA1 expression and
diminishing Drp1 expression (Ding et al., 2018; Elesela et al., 2020; X. Zhang, Kang, et al., 2020). Melatonin also regulates autophagy/mitophagy pathway (Coto-Montes et al., 2012). In
virus infected cells, melatonin shows different effect on autophagy markers including beclin-1, Atg5, Atg12 and Atg16L levels, and LC3-II/LC3-I ratio, dependent on the type of viruses
and infection time (Sang et al., 2018; San-Miguel et al., 2014).
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Coronaviruses alter mitochondrial dynamics and mitophagy to pro-
mote interference of cellular signaling pathways and tomaintain persis-
tent infection.
The SARS-CoV-2 ORF3a protein contains a 20-base sequence
targeting USP30 protein, a mitochondrial deubiquitinase. The USP30
protein promotes mitochondrial fusion through deubiquitinating
ubiquitylated forms of Mfn1 and Mfn2. Therefore, SARS-CoV-2 ORF3a
protein may inhibit mitochondrial fusion by targeting USP30 (Singh,
Chaubey, et al., 2020b). Furthermore, SARS-CoV-2 infected cells show10reduction in the expression of mitochondrial ribosomal, complex I and
mitochondrial fission promoting SOCS6 and MTFP1 genes. Decreased
expression of MTFP1 and SOCS6 results in the disruption of mitochon-
drial fission leading to hyperfused mitochondria, which is observed in
SARS-CoV-2 infected cells (Singh, Chen, et al., 2020).
Results from various studies show that different CoVs have different
effects on various autophagy components in different cells. It seems that
autophagic components are hijacked by CoVs to supply double-
membrane vesicles needed for virus replication. Porcine epidemic diar-
rhea virus (PEDV) activates autophagy in infectedVero cells and inhibits
NF-κB activation and subsequent production of proinflammatory
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ever, autophagy induction could be an early effective strategy for the
prevention of PEDV infection (Ko et al., 2017). Furthermore, infection
of porcine kidney-15 (PK-15) and swine testicular (ST) cells with trans-
missible gastroenteritis coronavirus (TGEV) causes an elevation of the
ratio of LC3-II to LC3-I resulting in the autophagosome accumulation
in these cells. Since pharmacological inhibition of autophagy results in
the elevation of TGEV replication, induction of autophagy may be a cel-
lular strategy to prevent TGEV pathogenicity in testicular and renal cells
(Guo et al., 2016a). In contrast, Zhu and colleges reported that TGEV in-
duces oxidative stress in porcine epithelial cells resulting in the reduc-
tion of Δψm. Although the reduction of Δψm is often associated with
cell apoptosis, TGEV infection does not promote the expected apoptosis.
In TGEV-infected cells, reduction of total mitochondrial mass, up-
regulation of p62/SQSTM1 mitochondrial level and an increase in LC3-
II/LC3-I ratio and Beclin 1 expression indicates that TGEV may induce
mitophagy to suppress oxidative stress and apoptosis for promoting
cell survival and possibly the viral infection (Zhu, Mou, Yang, Lin, &
Yang, 2016). The activity of nonlipidated LC3 is required for MHV repli-
cation, independent of intact host autophagy machinery; down-
regulation of LC3 expression, but not the suppression of ATG5 and
ATG7 which is required for autophagy pathway inhibits MHV replica-
tion in HeLa CEACAM1a cells(Reggiori et al., 2010; Z. Zhao et al.,
2007). Furthermore, the lack of ATG5 protein and autophagy inhibition
do not influenceMHV replication in bonemarrowderivedmacrophages
and embryonic fibroblasts (Z. Zhao et al., 2007). However, the impair-
ment of autophagy and the lack of ATG5 expression results in the inhi-
bition of MHV replication in embryonic stem cells (Prentice, Jerome,
Yoshimori, Mizushima, & Denison, 2004).
The NSP6 protein of avian coronavirus, infectious bronchitis virus,
MHV and SARS-CoV induces autophagosome generation from ER
independent of starvation (Cottam et al., 2011). Interestingly,
autophagosomes induced by NSP6 have a small diameter (0.5 μm)
resulting from NSP6-induced limitation in autophagosome expansion.
Since NSP6 protein does not affect SQSTM1 recruitment to auto-
phagosomes, small diameter autophagosomes induced by NSP6 can ac-
cumulate cargo and deliver autophagic cargo to lysosomes (Cottam,
Whelband, & Wileman, 2014). MERS-CoV is reported to inhibit Beclin1
expression and suppress autophagosomes-lysosome fusion. This effect
may be mediated by the poly-ubiquitination of Beclin1 through activat-
ing S-phase kinase-associated protein 2 (SKP2) as E3 ligase (Gassen
et al., 2019). However, inhibition of the PI3K/AKT/mTOR signaling
pathway is reported to inhibitMERS-CoV replication. Thesefinding sug-
gests that regulation of autophagy may be an important target for ther-
apeutic intervention strategies for MERS-CoV (Kindrachuk et al., 2015).
SARS-CoV and SARS-CoV-2 also result in perturbations specific as-
pects of autophagy and mitochondrial processes in infected cells (Fig
2). The ORF-9b protein of SARS-CoV localizes in mitochondria, where
it promotes proteasomal degradation of Drp1 leading to the mitochon-
drial elongation. This effect of ORF-9b in promotingmitochondrial elon-
gation is in contrast to the elimination of unhealthy mitochondria by
mitochondrial fission which occurs following viral infection. This sug-
gests that ORF-9b promotes cell survival during viral replication
through inhibition of mitochondrial fragmentation induced by other
cellular stresses. Therefore, SARS-CoV may use ORF-9b to maintain
viral replication by altering mitochondrial dynamics and targeting
MAVS to evade host innate immunity. Furthermore, permanent trans-
fection of cells with ORF-9b protein has no significant effect on LC3 pro-
cessing or induction of autophagy, but, acute ORF-9b expression results
in the significant induction of Atg5 expression and autophagosome for-
mation (X.-Y. Liu et al., 2010).
The USP30 protein also plays a role in mitochondria homeostasis
through cooperating with Parkin-mediated mitophagy. Thus,
SARS-CoV-2 by using ORF3a protein may alter ubiquitination in mito-
chondria through interacting with USP30; this leads to the mitochon-
drial collapse and premature death of infected cells (Zarandi,11Zinatizadeh, Zinatizadeh, Yousefi, & Rezaei, 2021) In ACE2-expressing
cells, infection with SARS-CoV-2 has been reported to up-regulate the
expression of PINK1; this suggests that SARS-CoV-2 may affect mito-
chondrial dynamics depending on the type of cells (Miller et al.,
2020). The expression of SKP2 reduces in SARS-CoV-2 infected cells,
which this results in the inhibition of Beclin1 degradation leading to
the induction of autophagic flux (Singh, Chen, et al., 2020). Since the
amino acid sequences of ORF-9b in SARS-CoV-2 are similar to SARS-
CoV (Singh, Chaubey, et al., 2020b), it is suggested that SARS-CoV-2
ORF-9b inhibits mitochondrial fragmentation and induces
autophagosome formation to promote cell survival for increasing viral
replication. However, coexpression network analysis of the RNA seq
data from SARS-CoV-2 infected cells demonstrates that SARS-CoV-2 im-
pairs autophagic flux through up-regulation of glycogen synthase ki-
nase 3 beta (GSK3B), or down-regulation of autophagy genes
including synaptosome associated protein 29 (SNAP29) and SQSTM1
as well as lysosome acidification genes (Singh, Chen, et al., 2020).
Based on these findings, it is proposed that CoVs activate autophagy
during infection but it is unclear why CoVs would limit autophagy.
More studies are needed to clarify the exact role of autophagy in the co-
ronavirus infection.
7.4. The regulatory effect of melatonin on mitochondrial dynamics and
autophagy
Melatonin inhibitsmitochondrial fission by down-regulating the ex-
pression of Drp1. This effect ofmelatoninmay bemediated by activation
of the sirtuin 1-PGC1α pathway; PGC-1α negatively regulates the ex-
pression of Drp1 by binding to its promoter. Since activation of sirtuin
1 improves Δψm and reduces generation of ROS during viral infection,
melatonin seems to improve mitochondrial function by induction of
sirtuin 1 expression; sirtuin 1 increases the expression of downstream
transcription factor PGC1αwhich, in addition to the reducing Drp1 ex-
pression, promotesmitochondrial biogenesis. These findings reveal that
melatonin may mediate mitochondrial adaptations through regulating
both mitochondrial dynamics and mitochondrial biogenesis (Ding
et al., 2018; Elesela et al., 2020). Melatonin is reported to inhibit
prion-induced neuron damage by regulating mitochondrial function
and dynamics. Melatonin corrects the imbalance of mitochondrial dy-
namics occurring in prion-induced neural cell damage by overexpress-
ing OPA1 and diminishing Drp1 expression (X. Zhang et al., 2020). In
addition to the reduction in Drp1 expression, melatonin reduces the
co-localization of Drp1 and Tom20 proteins, which indicates that mela-
tonin reducesmitochondrial translocation of Drp1 (HongyanZhou et al.,
2018). Suppression of Drp1-mediated mitochondrial fission by melato-
nin results in the inhibition of mitophagy-mediated cellular death by
preventingmitochondrial permeability transition pore (mPTP) opening
and PINK1/Parkin activation. Melatonin activates AMPKαwhich subse-
quently inhibits voltage-dependent anion channel 1 and hexokinase 2
disassociation-involved mPTP opening and excessive mitophagy. Fur-
thermore, AMPKα represses mitochondrial fission via inactivation of
Drp1 protein (Hao Zhou et al., 2017). Activation and mitochondrial
translocation of Drp1 is dependent on a variety of factors including
ROS overproduction and calcium overload; the inhibitory effect of mel-
atonin on Drp1 activation and mitochondrial translocation may also re-
sult from the antioxidant actions of melatonin and its inhibitory effect
on cytosolic calcium overload (Cui et al., 2018; S. Xu et al., 2016). Mela-
tonin also induces mitochondrial fusion in oxidative stress condition,
which this effect is mediated by the activation of AMPK/PGC1α path-
way; melatonin restores the expression of Mfn2 and OPA1, which are
reduced in oxidative stress condition (Qi & Wang, 2020).
The modulatory effect of melatonin on autophagy/mitophagy has
been reported in several investigations; however the exactmechanisms
are unknown (Coto-Montes et al., 2012). In normal cells,melatonin pro-
motes autophagy through activating AMPK, inducing the expression of
Beclin 1 and ATGs, down-regulating the mTOR-signaling pathway and
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autophagy to increase apoptotic death of cancer cells (Mehrzadi,
Hemati, et al., 2020). Melatonin reduces acute liver failure induced by
rabbit hemorrhagic disease virus (RHDV). Infection of rabbits with
RHDV is associated with the induction of autophagy characterized by
up-regulation of beclin-1, Atg5, Atg12, Atg16L and p62/SQSTM1 levels,
and LC3-II/LC3-I ratio; this autophagic response is inhibited by melato-
nin administration (San-Miguel et al., 2014). Myocarditis induced by
coxsackievirus B3 is also associated with the alteration in autophagy.
The autophagy markers including LC3-II/LC3-I ratio and Beclin-1 in-
crease on day 7 and 14 after viral infection; following melatonin treat-
ment, these markers are diminished on day 7 and then trend upward
to day 14 (Sang et al., 2018). As alreadymentioned, SARS-CoV-2 induces
oxidative stress in infected cells, similar to other viruses, which this re-
sults in the disruption of mitochondrial function. Since melatonin is a
powerful antioxidant with the ability to regulate mitochondrial dynam-
ics and autophagy/mitophagy, this indoleamine may inhibit SARS-CoV-
2 replication and protect cells from coronavirus-induced damage
through inhibiting oxidative stress and improving SARS-CoV-2-
induced perturbation in mitochondrial fusion, fission and autophagy
(Fig 2).
8. Apoptosis and mitochondrial quality control
The mixture of healthy mitochondria with defective mitochondria
during the fusion process can repair dysfunctional mitochondria;
however, when mitochondrial damage is extensive, dysfunctional
mitochondria are segregated by fission, with these organelles ulti-
mately being eliminated by mitophagy. If the quality control at mo-
lecular and organelle levels are impaired or the mitochondrial
damage is greater than the capacity of fission/fusion and mitophagy
pathways, defective mitochondria can rupture (Q. Cai & Tammineni,
2016). Following mitochondrial rupture, apoptotic factors escape
from the mitochondrion to the cytosol and trigger apoptotic cell
death through induction of caspase activation as well as chromosome
condensation and fragmentation. The release of these apoptotic
factors occurs when the integrity of OMM is compromised by the
pro-apoptotic Bcl-2 family members. Once activated, pro-apoptotic
members of Bcl2 family proteins including Bax and Bak form mPTP
leading to permeabilization of the mitochondrial outer membrane
(Westphal, Kluck, & Dewson, 2014); this process leads to the release
of apoptotic proteins including Smac/DiaBLO, HtrA2/Omi, apoptosis
inducing factor (AIF), endonuclease G (EndoG) and cytochrome c
from the IMM space into the cytosol (Q. Cai & Tammineni, 2016;
Martinou & Youle, 2011). In the cytoplasm, cytochrome c interacts
with apoptosis protease-activating factor 1 (Apaf-1) and procaspase-9
to create the apoptosome complex. The apoptosome catalyzes the au-
tocatalytic activation of caspase-9, which subsequently activates cas-
pase 3. Once activated, caspase 3 cleaves vital cellular proteins and
executes cell death (Fig 2) (Montero & Letai, 2018). In addition to cas-
pase, cell death factors released from mitochondria may activate
caspase-independent apoptosis. SMAC/Diablo and HtrA2/Omi pro-
motes caspase activity by neutralizing the inhibitory effect of inhibi-
tor of apoptosis proteins (IAPs) on caspases. Furthermore, AIF is
translocated into the nucleus, where it binds chromosomal DNA and
causes chromatin condensation, thereby, directly or indirectly
allowing DNA fragmentation by Endo G (Lartigue et al., 2009). Fur-
thermore, Bax/Bak promotes sumoylation of Drp1 leading to the in-
duction of a stable membrane-associated form of Drp1 during
apoptosis. Detection of the active Bax in discrete foci at mitochondrial
fission sites reveals a link between mitochondrial fission and Bax
activation. This indicates a link between Bcl-2 family members and
mitochondrial dynamics; however, the connection between the
mitochondrial fragmentation during apoptosis and Bcl-2 family pro-
teins effects on mitochondrial dynamics is unknown (Martinou &
Youle, 2011).128.1. Effects of viral infection on mitochondrial apoptosis
Two defensive arms which are used by multicellular organisms to
overcome viral infections include activation of innate immune re-
sponses and induction of programmed cell death. During viral infec-
tions, activation of apoptotic pathways in host cells may be an
effective strategy to prevent viral infections by inhibiting viral replica-
tion and limiting virus spreading (Cuconati & White, 2002). Thus, inhi-
bition of apoptotic pathways may be a strategy by which viruses
maintain their replicative ability. However, results from experimental
studies indicate that CoVs encode either pro-apoptotic or anti-
apoptotic proteins in infected cells; this suggests that apoptosis may
be regulated differently depending on particular virus–host interactions
(Y.-J. Tan, Lim, & Hong, 2007).
During an MHV infection, the expression of pro-apoptotic gene
BNip3 is reduced in astrocytes. This repression in the BNip3 expression
has been observed for live and ultraviolet light-inactivated viruses; this
indicates that viruses down-regulate BNip3 expression during cell entry
showing that it is not required for virus replication (Y. Cai, Liu, Yu, &
Zhang, 2003). Caspase recruitment domains (CARDs) are homotypic in-
teraction motifs found in various proteins which are involved in both
apoptotic and inflammatory signaling cascades. Caspases, Apaf-1 and
some members of the NLR (nucleotide-binding domain and
leucine-rich repeat containing) protein family are among the proteins
that contain the domain. As already mentioned, Apaf-1 interacts with
cytochrome c to form the apoptosome which functions to activate
caspase-9, thereby stimulating mitochondria-dependent apoptotic sig-
naling. The CARD-containing NLR such as Nod1, Nod2 and Nlrc4 (Ipaf)
have been linked to both apoptotic and inflammatory signaling (Y. Lei
et al., 2009). The MAVS protein also contains a N-terminal CARD-like
domain, which suggests that mitochondrial localization of MAVS pro-
tein is involved in the induction of apoptosis, in addition to the innate
immunity response. Therefore, inhibition of MAVS function may be a
successful strategy for some viruses to inhibit cell death responses (Y.
Lei et al., 2009; X.-D. Li, Sun, Seth, Pineda, & Chen, 2005). SARS-CoV
has also been shown to inhibit MAVS-mediated apoptotic responses,
in addition to inhibition of IFN-I responses; SARS-CoV NSP15 protein,
an important protein for SARS-CoV replication, completely abrogates
MAVS-induced apoptosis. The exact mechanism by which SARS-CoV
NSP15 inhibits MAVS-induced cell death is not fully understood (Y. Lei
et al., 2009). The murine coronavirus NSP15 prevents detection of
viral dsRNA by RIG-I and MDA5 sensors of macrophages, which are
equipped with multiple dsRNA sensors; this results in the delay in the
activation of IFN and inhibition of macrophage apoptosis (Deng et al.,
2017).
Various studies also indicate the existence of pro-apoptotic proteins
including ORF-3a, ORF-3b, ORF4, ORF-6, ORF7a and ORF7b in SARS-CoV
genome, which result in the induction of apoptosis in specific cell types
(Ye, Wong, Li, & Xie, 2008; Yuan, Shan, Zhao, Chen, & Cong, 2005). The
ORF-3a protein, a viral protein localized to the ER, induces chromatin
condensation and DNA fragmentation leading to apoptosis in SARS-
CoV-susceptible cells (Law et al., 2005); this protein is reported to pro-
mote mitochondrial apoptosis through activation of p38 MAP kinase
(MAPK) (Padhan, Minakshi, Towheed, & Jameel, 2008). The 3b protein
(ORF4) is found in both the nucleus and mitochondria and its overex-
pression leads to the induction of cell cycle arrest at the G0/G1 phase
(Yuan et al., 2005). OverexpressionORF-6 induces apoptosis by promot-
ing ER stress resulting in the activation of caspase-3 and JNK MAPK
pathway (Ye et al., 2008). The ORF7a protein may interact with anti-
apoptotic protein Bcl-XL in the ER, leading to the sequestration of Bcl-
XL in the Golgi apparatus; this subsequently tips the balance towards
apoptosis, with this being associated with the activation of p38 MAPK
(Schaecher, Touchette, Schriewer, Buller, & Pekosz, 2007). The ORF7a
protein also interacts with human Ap4A-hydrolase (asymmetrical
diadenosine tetraphosphate hydrolase, EC 3.6.1.17), a member of a su-
perfamily of enzymes involved in the elimination of cells from toxic
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anisms leading to cell cycle arrest and apoptosis (Vasilenko,
Moshynskyy, & Zakhartchouk, 2010). Furthermore, ORF7a protein in-
duces apoptosis through interfering with Bcl-XL and other pro-
survival proteins (Bcl-2, Bcl-w, Mcl-1, and A1) (Tan et al., 2007). The
SARS-CoVmembrane (M) structural protein induces apoptosis through
the regulation of Akt pro-survival pathway and induction of mitochon-
drial cytochrome c release (C.-M. Chan, Ma, Chan, & Chan, 2007). The
expression of ORF8a has also been reported to be increased in SARS-
CoV infected patients. The ORF8a protein induces apoptosis in addition
to the viral replication indicating that this protein plays an important
role in the SARS-CoV pathogenesis. The ORF8a protein is localized inmi-
tochondria, where it inducesmitochondrial hyperpolarization, overpro-
duction of ROS, and subsequent caspase 3-dependent apoptosis (Fig 2)
(C.-Y. Chen et al., 2007).
The SARS-CoV-2 ORF3a protein also induces apoptotic cell death by
promoting the activation of caspase-3, truncation of Bid (tBid), cleavage
of caspase-9, and release of cytochrome c (Ren et al., 2020). SARS-CoV-2
induces apoptosis in lymphocytes (CD3, CD4, and CD8 T cells) leading
to a reduction of lymphocyte count; this results in the cytokine storm
syndrome associated with the uncontrolled production of pro-
inflammatory cytokines, leading to the hyper-inflammation as well as
cellular and, eventually, organ destruction (Gao et al., 2020; Juybari
et al., 2020). The non-clonal population of T cells found in acutely in-
fected COVID-19 patients is characterized by up-regulating the expres-
sion of voltage dependent anion channel, mitochondrial membrane
protein involved in outer mitochondrial membrane permeabilization
and induction of cell death. The increased expression of voltage depen-
dent anion channel in these T cells is associated with the mitochondrial
dysfunction leading to the release of cytochrome c and activation of
caspases; this caspases-induced T cell apoptosis may contribute to the
lymphopenia, observed in COVID19 patients (Thompson et al., 2020).
Since the inhibition of SARS-CoV-induced apoptosis does not alter sus-
ceptibility of cells to infection or viral replication and release, apoptosis
seemsmay not be involved in facilitating production and dissemination
of CoVs (Bordi et al., 2006). These findings suggest that apoptosis may
be activated due to alterations in host-infected cells; however further
studies are needed to determine that SARS-CoV-2-induced apoptosis re-
sults from virus replication; alternatively, it may be a response of the in-
fected cell to virus-induced stress.
8.2. The regulatory effect of melatonin on mitochondrial apoptosis
The influence of melatonin on the processes of apoptosis has been
evaluated in various cells and tissues (Fig 2). The actions of melatonin
in healthy and tumor cells are clearly different (K. H. Lu et al., 2018; R. J.
Reiter et al., 2017; Su et al., 2017). Intracellular interactions of melatonin
contributes to the stimulation of apoptosis in cancer cells (Bizzarri,
Proietti, Cucina, & Reiter, 2013; Pourhanifeh, Mehrzadi, Kamali, &
Hosseinzadeh, 2020), while it prevents apoptotic cell death in healthy
cells (Pourhanifeh, Mehrzadi, & Hosseinzadeh, 2020); the specific expla-
nation for this differential response is not known but could relate to any
of a number of cellular processes including intercellular signaling,metab-
olism, gene regulation, or stress responses (Sainz et al., 2003;H.M. Zhang
&Zhang, 2014). In viral infected cells,melatoninmaymodulate apoptosis
and differentially regulate the expression of pro-apoptotic and anti-
apoptotic mediators to limit the extent of viral spread. Since viruses are
dependent on the host for each stage of replication, these intracellular
parasites cause cell stress and alter expression of genes regulating cell
survival (Boga, Coto-Montes, Rosales-Corral, Tan, & Reiter, 2012).
The anti-apoptotic properties of melatonin are related to its regula-
tory actions on mitochondrial function as well as on its antioxidant
and free-radical scavenging activities. Melatonin maintains more opti-
mal mitochondrial physiology by inhibiting the mPTP opening as well
as suppressing oxidative stress-induced Ca2+ overload, which subse-
quently inhibits mitochondrial membrane depolarization, Ca2+-13mediated mPTP opening and Ca2+-induced Ca2+ release (Andrabi,
Sayeed, Siemen, Wolf, & Horn, 2004; Suwanjang, Abramov,
Charngkaew, Govitrapong, & Chetsawang, 2016). Furthermore, melato-
nin stabilizes the level of parvalbumin and hippocalcin, as Ca2+-
buffering proteins, resulting in the prevention of large rises intracellular
Ca2+ levels and induction of apoptosis (Koh, 2012).Melatonin is also ca-
pable of both donating and accepting electrons to mitochondrial ETC
omplexes; this contributes to the enhancement of the activities of respi-
ratory complexes I, III and IV and in the maintenance of efficient oxida-
tive phosphorylation and ATP synthesis (López et al., 2009; Martín,
Macías, Escames, León, & Acuña-Castroviejo, 2000). By influencing
these processes, melatonin improves mitochondrial respiration and en-
ergy production, thereby limiting mitochondrial depolarization, mPTP
opening, and the release of apoptotic proteins such as Smac/DiaBLO,
HtrA2/Omi, AIF, EndoG and cytochrome c from IMMspace into the cyto-
sol (Acuna-Castroviejo, Escames, Rodriguez, & Lopez, 2007). Melatonin
inhibits Bax activation/dimerization within mitochondria by stimulat-
ing Bcl-2 localization in OMM; this effect of melatonin is mediated by
the activation of plasma membrane MT1/MT2 receptors. Inhibition of
Bax activation/dimerization prevents the formation ofmPTP and release
of pro-apoptotic factors from mitochondria (Radogna et al., 2007;
Radogna et al., 2008). In a mechanism related to the activation of mem-
brane MT1 and MT2 receptors, melatonin inhibits phosphorylation of
p53 by down-regulating phosphorylation of JNK and p-38 MAPKs; this
leads to the reduction of Bax/Bcl-2 ratio, inhibition of cytochrome c re-
lease, and prevention of Bid proteolytic cleavage and activation of
caspases (Das et al., 2010). Furthermore, melatonin binds toMT1 recep-
tors localized in OMM leading to the activation of MT1/Gαi signaling in
the mitochondrial intermembrane space; this event suppresses adenyl-
ate cyclase activity and inhibits Ca2+-mediated cytochrome c release,
thereby preventing caspase activation (Suofu et al., 2017).
The anti-apoptotic effect of melatonin has been reported in some
virus-infected cells, e.g., during a venezuelan equine encephalitis
(VEE) virus (VEEE) infection. Pre-treatment with melatonin clearly
modified the VEE infection since it reduced apoptosis in infected mice
and in VEEV-infected neuroblastoma cells (Montiel et al., 2015). Mela-
tonin also inhibits apoptosis of hepatocytes induced by RHDV; this ef-
fect is associated with the up-regulation of Bcl-2 and Bcl-xL
expressions and down-regulation of Bax expression, cytochrome c re-
lease and caspase-9 activation (Tuñón et al., 2011). Melatonin restores
mitochondrial function in cardiomyocyte infected with coxsackievirus
B3, which subsequently leads to the inhibition of apoptotic cell death
(Ouyang et al., 2019; Sang et al., 2018). Since SARS-CoV-2 induces the
release of cytochrome c and subsequently activates caspase-3 in in-
fected cells, mitochondrial dysfunction is suggested to be a mechanism
by which SARS-CoV-2 induces apoptosis. The findings summarized
above suggest that a reduction of melatonin levels in the mitochondria
of SARS-CoV-2 infected cells may contribute to the dysregulation
of cellular and mitochondrial metabolisms (Anderson & Reiter, 2020).
Therefore, treatment with melatonin may inhibit apoptosis induced by
SARS-CoV-2 in infected cells by regulating mitochondrial physiology.
9. Conclusion
This review summarizes the consequences of a CoVs infection on the
molecular pathways involved in the mitochondrial protein quality con-
trol. Impairment of mitochondrial function may be an important mech-
anismbywhich CoVs influence innate immune signaling and survival of
infected cells. The protective actions of melatonin on mitochondrial
function suggest that this molecule likely would protect coronavirus-
infected cells against virus-induced mitochondrial dysfunction. In addi-
tion to the direct mitochondrial protective actions, melatonin could in-
directly impact mitochondrial quality control by regulating proteasome
activity, mitochondrial dynamics, autophagy and apoptosis. However,
further studies are needed to clarify the effect of CoVs such as SARS-
CoV-2 on mitochondrial quality control and melatonin effects on
S. Mehrzadi, M.Y. Karimi, A. Fatemi et al. Pharmacology & Therapeutics 224 (2021) 107825signaling pathways dysregulated by these viruses. This review will
hopefully stimulate additional research related to the mechanisms of
action of melatonin against CoVs-induced cell damage.
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